Important Information
This Summary of Safety and Clinical Performance (SSCP) is intended
to provide public access to an updated summary of the main aspects
of the safety and clinical performance of the device. The
information presented below is intended for patients or lay
persons. A more extensive summary of safety and clinical
performance prepared for healthcare professionals is found in the
first part of this document.
The SSCP is not intended to give general advice on the treatment
of a medical condition. Please contact your healthcare
professional in case you have questions about your medical
condition or about the use of the device in your situation. This
SSCP is not intended to replace an Implant Card or the
Instructions for Use to provide information on the safe use of the
device.
1. Device Identification and General Information
Device Trade Name(s): Vascu-PICC® Peripherally
Inserted Central Catheter
Manufacturer Name and Address: Medical
Components, Inc. 1499 Delp Drive Harleysville, PA 19438 USA
Basic UDI-DI: 00884908288NT
Date First CE Certificate Was Issued for This Device:
Vascu-PICC® - June 2005 Jet-PICC - August 2002
Device Grouping and Variants
The devices in scope of this document are all peripherally
inserted central catheter (PICC) sets. The catheter part numbers
are organized into variant categories. These devices are
distributed as sets. Sets come in different configurations.
Variant Devices:
Sets:
| Variant Description |
Part Number(s) |
| JMP4D |
10534-860-001 |
| JMP5D |
10535-860-001 |
| JMP6D |
10536-860-001 |
| MR17014201 |
10534-860-001 |
| MR17014205 |
10534-860-001 |
| MR17015201 |
10535-860-001 |
| MR17015205 |
10535-860-001 |
| MR17016201 |
10536-860-001 |
| JMP5S |
10529-860-001 |
| MR17013101 |
10527-860-001 |
| MR17013105 |
10527-860-001 |
| MR17014101 |
10528-860-001 |
| MR17014105 |
10528-860-001 |
| MR17015101 |
10529-860-001 |
| MR17015105 |
10529-860-001 |
Sets:
| Variant Description |
Part Number(s) |
Procedure Trays:
Configurations of Sets:
| Catalog Code |
Part Number |
Description |
| Vascu-PICC® Basic Set |
– |
|
| Vascu-PICC® Nursing Set |
– |
|
| Jet-PICC Basic Set |
– |
|
Configurations of Sets:
| Catalog Code |
Part Number |
Description |
| Vascu-PICC® Basic Set |
– |
|
| Vascu-PICC® Nursing Set |
– |
|
| Jet-PICC Basic Set |
– |
|
Configurations of Procedure Trays:
| Configuration Type |
| Vascu-PICC® Basic Set: |
| Vascu-PICC® Nursing Set: |
| Jet-PICC Basic Set: |
2. Intended Use of the Device
Intended Purpose: The Vascu-PICC®/Jet-PICC
Peripherally Inserted Central Catheters are for use in adult
patients requiring needing needlesticks for whom short-term or
long-term peripheral access to the central venous system without
requiring frequent needlesticks is deemed necessary based on the
direction of a qualified, licensed physician.
Indication(s): The Vascu-PICC®/Jet-PICC
Peripherally Inserted Central Catheter is for short-term or
long-term peripheral access to the central venous system for the
intravenous administration of fluids or medications.
Intended Patient Group(s): Vascu-PICC®/Jet-PICC
Peripherally Inserted Central Catheters are intended for use in
adult patients requiring frequent needlesticks for whom short-term
or long-term peripheral access to the central venous system
without requiring frequent needlesticks is deemed necessary based
on the direction of a qualified, licensed physician. The device is
not intended for use in pediatric patients.
Contraindications and/or Limitations:
-
This catheter is not intended for any use other than that which
is indicated. Do not implant catheter in thrombosed vessels.
-
The presence of skin related problems around the insertion site
(infection, phlebitis, scars, etc.)
-
The presence of device related bacteremia or septicemia.
- History of mastectomy on insertion side.
-
Previous history of venous/subclavian thrombosis or vascular
surgical procedures at insertion site.
- Fever of unknown origin.
-
The patient's body size is insufficient to accommodate the size
of the implanted device.
-
The patient is known or is suspected to be allergic to materials
contained in the device.
-
Past irradiation of prospective insertion site.
-
Local tissue factors will prevent proper device stabilization
and/or access.
3. Device Description
Device Name: Vascu-PICC®
Description of Device: The Vascu-PICC®
Peripherally Inserted Central Catheters are designed for
peripheral vein catheterization. The lumen is an open-ended design
comprised of a radiopaque polyurethane material with barium
sulfate for radiopacity. The lumen is connected to the extensions
via a molded hub with integral suture wings for catheter
securement. Clamps are provided on the extension tubes to prevent
air/fluid mixing. Female connectors provide the connection for
intravenous administration. The devices are available in a range
of French sizes in single and dual lumen configurations. The lumen
has depth marks every centimeter and numerical marks every 5th
centimeter and are available in trimmable 60cm for PICC's. The
Vascu-PICC® Peripherally Inserted Central Catheter product line is
packaged sterile with the necessary accessories to facilitate
catheter insertion.
Device Name: Jet-PICC
Description of Device: The Jet-PICC Peripherally
Inserted Central Catheters are designed for peripheral vein
catheterization. The lumen is an open-ended design comprised of a
radiopaque polyurethane material with barium sulfate for
radiopacity. The lumen is connected to the extensions via a molded
hub with integral suture wings for catheter security. Clamps are
provided on the extension tubes to prevent air/fluid mixing.
Female connectors provide the connection for intravenous
administration. The catheters are available in a range of French
sizes in single and dual lumen configurations. The lumen has depth
marks every centimeter and numerical marks every 5th centimeter
and are available in trimmable 60cm for PICC's. Jet-PICC
Peripherally Inserted Central Catheter product line is packaged
sterile with the necessary accessories to facilitate catheter
insertion.
Materials / Substances in Contact with Patient Tissue:
The percentage ranges below are based on catheter weights. The 3F
x 60 Single Lumen device weighs 2.70 grams. The 6F x 60cm Double
Lumen device weighs 7.86 grams.
Material
| Material |
% Weight (w/w) |
| Polyurethane |
48.76-63.36 |
| Acetal Co-polymer |
18.32-31.3 |
| Acrylonitrile Butadiene Styrene |
7.93-13.55 |
| Barium Sulfate |
5.60-8.30 |
The percentage ranges below are based on catheter weights. The 3F
x 60 Single Lumen device weighs 2.70 grams. The 6F x 60cm Double
Lumen device weighs 7.86 grams.
Material
| Material |
% Weight (w/w) |
| Polyurethane |
48.76-63.36 |
| Acetal Co-polymer |
18.32-31.3 |
| Acrylonitrile Butadiene Styrene |
7.93-13.55 |
| Barium Sulfate |
5.60-8.30 |
Note: Accessories containing stainless steel may contain up to
0.4% weight of the CMR substance cobalt.:
Note: The device should not be used if you are allergic to the
above materials.:
Information on Medicinal Substances in the Device:
How the Device Achieves its Intended Mode of Action:
The subject devices utilize a Seldinger or Modified Seldinger
technique to obtain the desired access. The primary difference is
one technique utilizes an Introduction Sheath and one does not.
The Seldinger techniques for venous access are well-established
surgical techniques utilized for insertion of PICC devices. The
instructions for use of each catheter are detailed in the
respective product IFUs. Catheters are to be inserted, manipulated
and removed by a qualified, licensed physician or other qualified
health care professional utilizing strict aseptic technique. Once
in place, fluids are given or blood is withdrawn via the PICC
catheter most commonly with a disposable tubing set or syringe.
Catheter care includes use of a locking solution to maintain
catheter function. Catheter removal is normally accomplished by
gently pulling on the catheter.
Cleaning (Sterilization) Information: Contents
sterile and non-pyrogenic in unopened, undamaged package.
Sterilized by Ethylene Oxide.
Accessories Intended for Use in Combination with the
Device:
| Name of Accessory |
Description of Accessory |
| Guidewire |
Acts as a path for other components. |
| Introducer Needle |
Placed into the target vein to gain access.
|
| Stylet |
Assists in catheter placement. |
| Peelable Introducer |
Used to get central venous access. |
| Scalpel |
A cutting device. |
| Tourniquet |
Stops the flow of blood. |
| Securement Device |
Stabilization device. |
| Syringe |
Helps get blood return once the needle punctures the vein.
|
4. Risks and Warnings
Contact your healthcare professional if you believe you are
experiencing side-effects related to the device or its use or if
you are concerned about risks. This document does not replace a
consultation with your healthcare professional if needed.
How Potential Risks Have Been Controlled or Managed
There have been 97,169 devices sold since January 2019. There are
side effects and risks associated with the device. These include:
Infection Bleeding Catheter Removal Catheter Replacement These
risks are reduced to an acceptable level. The labeling describes
the risks. The benefit of the device is facilitating peripheral
access when alternatives are not suitable. These benefits outweigh
the risks.
Remaining Risks and Undesirable Effects
The Vascu-PICC® Peripherally Inserted Central Catheter is
associated with risks. These include:
Procedural Delays
Thrombosis
Infections
Perforations
Embolism
Cardiac Event
Dissatisfaction These risks are consistent with risks of other
peripherally inserted central catheters. They are not unique to
the Medcomp product. Some of the most common reactions include
infection. Infection may be associated with general surgical
procedure and hospitalization. Infection may not always be
device-related.
|
Quantification of Residual Risks
|
|
PMS Complaints (01 January 2019 – 30 June 2023)
|
PMCF Events |
|
Units Sold: 97,169 |
Units Studied: 20 |
|
Patient Residual Harm Category
|
# of Cases Per Event |
# of Cases Per Event |
| Allergic Reaction |
Not Reported. |
Not Reported. |
| Bleeding |
Not Reported. |
Not Reported. |
| Cardiac Event |
Not Reported. |
Not Reported. |
| Embolism |
Not Reported. |
Not Reported. |
| Infection |
Not Reported. |
Not Reported. |
| Perforation |
Not Reported. |
Not Reported. |
| Stenosis |
Not Reported. |
Not Reported. |
| Tissue Injury |
Not Reported. |
Not Reported. |
| Thrombosis |
Not Reported. |
Not Reported. |
Warnings and Precautions
The below are warnings, precautions, or measures to be taken by
patient:
Keep catheter dressing clean and dry. Ask your doctor for specific
instructions on how to care for your catheter.
Avoid letting the catheter or catheter site go under water.
Moisture near the catheter site can potentially lead to an
infection. Patients must not swim, shower or soak dressing while
bathing.
Contact your doctor right away if you notice any signs or symptoms
of your catheter complications, such as o The area around your
line is getting red, swollen, bruised or warm to the touch. o
Drainage from your catheter site. o The length of the catheter
that sticks out of your insertion site gets longer. o Difficulty
flushing your line because it seems to be blocked.
Avoid lifting heavy objects. Do not have blood pressure readings
taken on arm where the catheter is placed
Summary of Any Field Safety Correction Action (FSCA)
There were no recalls for the subject device from 01 January 2016
to 30 June 2023.
5. Summary of Clinical Evaluation and Post-Market Clinical
Follow-Up
Clinical Background of Device
The subject devices have been available since 2002. The CE Mark
was received in August 2002. US FDA clearance was in April 2003.
All models included are planned for distribution in the European
Union.
Clinical Evidence for CE-Marking
The clinical literature review identified 3 articles relating to
the safety and/or performance of the subject device when used as
intended. These articles included approximately 3,147 cases. Two
patient level data activities received information on 20
catheters. 28 user surveys have been received relating to this
device. Findings from the clinical literature and data activities
support the performance of the subject device. All data on the
Vascu-PICC® catheter has been evaluated. The benefits of the
subject device outweigh the risks when the device is used as
intended. The benefit of the device is facilitating peripheral
access to the central venous system in patients in whom other
therapies are not indicated or desirable as determined by the
physician.
Safety
There is sufficient data to prove conformity to the applicable
requirements. The device is safe and performs as intended and
claimed by Medcomp. The device is state of the art for allowing
peripheral access to the central venous system. Medcomp has
reviewed:
Post-Market Data
Medcomp Information Materials
Risk Management Documentation The risks are appropriately
displayed and consistent with the state of the art. The risks
associated with the device are acceptable when weighed against the
benefits. There were 97,169 devices sold from January 1st, 2019,
to June 30th, 2023. Also, during this period there were five
complaints received resulting in a 0.005% complaint frequency for
the Non-PI PICC product family.
6. Possible Therapeutic Alternatives
When considering alternative treatments, it is recommended to
contact your healthcare professional who can consider your
individual situation. The Infusion Nurses Society (INS) Standards
2021 clinical practice guidelines have been used to support the
below recommendations for treatments.
| Therapy |
Benefits |
Disadvantages |
Key Risks |
| • Central Venous Catheters (CVCs) |
- Easy access.
- Minimizes repeat puncture.
- Increased patient mobility.
- Easier for outpatients.
|
- Requires surgery.
- Surgery risks.
- Requires maintenance.
-
High risk of infection or thrombosis.
|
- Infection
- Occlusion
- Malfunction
- Thrombosis
|
| • Implantable Ports |
- Less Vein Damage.
- Easier to See and Access.
-
Reduces chance for corrosive medications to make skin
contact
- One puncture location.
- Longer Dwell Time.
- Can be permanent.
|
- Requires surgery.
- Surgery Risks.
- Requires maintenance.
|
- Infection
- Embolism
- Necrosis
|
| • Midline Catheters |
- Patient comfort.
- Longer dwell time than PIVs.
-
Lower risk of infection compared to IVs
- No X-ray required.
-
Decreased chance of extravasation.
|
-
Not suitable for continuous injections of most vesicants
or irritants
|
|
|
• Peripherally Inserted Central Catheters (PICCs)
|
-
Decreased risk of catheter occlusion compared to CVC
- Fewer punctures compared to PIV
|
-
Increased risk of deep vein thrombosis compared to CVC
- Pain/Discomfort over time
- Daily Life Adaption
|
- Deep vein thrombosis (DVT)
- Pulmonary embolism
- Venous thromboembolism (VTE)
- Post thrombotic syndrome
|
|
• Peripheral Intravenous Catheters (PIVs)
|
|
- Infection
- Bleeding
- Thrombosis
-
Cannot be used for therapies with blistering agents
- Four days maximum use.
|
|
7. Suggested Profile and Training for Users
The catheter should be inserted, manipulated, and removed by a
qualified, licensed physician or other qualified health care
professional under the direction of a physician.
Acronyms
| Abbreviation |
Definition |
| CE |
Conformité Européenne (European Conformity)
|
| cm |
centimeter |
| CMR |
Carcinogenic, mutagenic, reprotoxic |
| CVC |
Central Venous Catheter |
| dba |
Doing Business As |
| F |
French (thickness of catheter) |
| FDA |
Food and Drug Administration |
| FSCA |
Field Safety Corrective Action |
| INS |
Infusion Nurses Society |
| IV |
Intravenous |
| N/A |
Not Applicable |
| PA |
Pennsylvania |
| PICC |
Peripherally Inserted Central Catheter
|
| PIV |
Peripheral Intravenous Catheters |
| SSCP |
Summary of Safety and Clinical Performance
|
| USA |
United States of America |
| w/w |
Weight over Weight |